The North America Antacids Market would witness market growth of 2.5% CAGR during the forecast period (2023-2029).
Antacids may be used to alleviate some of the symptoms brought on by stomach ulcers and duodenal ulcers in the gut. These may also be used when neutralizing stomach acid is beneficial in other circumstances, such as sporadic episodes of dyspepsia. It functions by counteracting the acid produced in the stomach. They do this because antacids include bases (also known as alkalis), which are the chemical opposites of acids. Neutralization refers to the reaction between a base and an acid. The stomach contents are less caustic as a result of this neutralization. This may lessen ulcer-related pain as well as the burning that comes with acid reflux.
When antacids neutralize stomach acid, gas can be produced that may result in wind (flatulence). Simethicone, an ingredient frequently found in antacid medicines, helps prevent this foaming effect. Alginates are present in a large number of popular antacids. Most alginates function by creating a gel that floats over the stomach contents. By serving as a barrier, the gel stops stomach acid from aggravating the esophagus.
The rising incidence of gastro-esophageal illnesses and the aging population are increasing the demand in the region. Due to changes in lifestyle and other factors, the majority of Americans experience gastroesophageal reflux disease (GERD). In addition, over 60 million people in North America report having heartburn every once a month, resulting in heartburn becoming a common problem. Similarly, there are millions of antacid users in Canada. Antacids are explicitly advised for usage by Canadians by Health Canada. The FDA requested that manufacturers conduct more studies and testing on each antacid pill, as well as on how much of it to use and any potential side effects. These factors collectively propel the antacid market in this region forward.
The US market dominated the North America Antacids Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $2,157.2 Million by 2029. The Canada market is poised to grow at a CAGR of 4.5% during (2023 - 2029). Additionally, The Mexico market would witness a CAGR of 4.3% during (2023 - 2029).
Based on Formulation Type, the market is segmented into Tablets, Liquids and Others. Based on Mechanism of Action, the market is segmented into Non-systemic and Systemic. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Antacids Market is Projected to reach USD 7.9 Billion by 2029, at a CAGR of 3.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Alkem Laboratories Ltd., Bayer AG, Cipla Limited, Pfizer, Inc., Prestige Consumer Healthcare, Inc., Reckitt Benckiser Group PLC, WellSpring Pharmaceutical Corporation (Avista Capital Partners), Sanofi S.A. and Sun Pharmaceutical Industries Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Formulation Type
By Mechanism of Action
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Alkem Laboratories Ltd.
- Bayer AG
- Cipla Limited
- Pfizer, Inc.
- Prestige Consumer Healthcare, Inc.
- Reckitt Benckiser Group PLC
- WellSpring Pharmaceutical Corporation (Avista Capital Partners)
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Antacids Market, by Formulation Type
1.4.2 North America Antacids Market, by Mechanism of Action
1.4.3 North America Antacids Market, by Distribution Channel
1.4.4 North America Antacids Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Antacids Market by Formulation Type
3.1 North America Tablets Market by Country
3.2 North America Liquids Market by Country
3.3 North America Others Market by Country
Chapter 4. North America Antacids Market by Mechanism of Action
4.1 North America Non-systemic Market by Country
4.2 North America Systemic Market by Country
Chapter 5. North America Antacids Market by Distribution Channel
5.1 North America Drug Store & Retail Pharmacies Market by Country
5.2 North America Hospital Pharmacies Market by Country
5.3 North America Online Pharmacies Market by Country
Chapter 6. North America Antacids Market by Country
6.1 US Antacids Market
6.1.1 US Antacids Market by Formulation Type
6.1.2 US Antacids Market by Mechanism of Action
6.1.3 US Antacids Market by Distribution Channel
6.2 Canada Antacids Market
6.2.1 Canada Antacids Market by Formulation Type
6.2.2 Canada Antacids Market by Mechanism of Action
6.2.3 Canada Antacids Market by Distribution Channel
6.3 Mexico Antacids Market
6.3.1 Mexico Antacids Market by Formulation Type
6.3.2 Mexico Antacids Market by Mechanism of Action
6.3.3 Mexico Antacids Market by Distribution Channel
6.4 Rest of North America Antacids Market
6.4.1 Rest of North America Antacids Market by Formulation Type
6.4.2 Rest of North America Antacids Market by Mechanism of Action
6.4.3 Rest of North America Antacids Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Alkem Laboratories Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Bayer AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 SWOT Analysis
7.4 Cipla Limited
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional & Segmental Analysis
7.5.4 Research & Development Expense
7.6 Prestige Consumer Healthcare, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.7 Reckitt Benckiser Group PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 WellSpring Pharmaceutical Corporation (Avista Capital Partners)
7.8.1 Company Overview
7.9 Sanofi S.A.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.10. Sun Pharmaceutical Industries Ltd.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses
TABLE 1 North America Antacids Market, 2019 - 2022, USD Million
TABLE 2 North America Antacids Market, 2023 - 2029, USD Million
TABLE 3 North America Antacids Market by Formulation Type, 2019 - 2022, USD Million
TABLE 4 North America Antacids Market by Formulation Type, 2023 - 2029, USD Million
TABLE 5 North America Tablets Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Tablets Market by Country, 2023 - 2029, USD Million
TABLE 7 North America Liquids Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Liquids Market by Country, 2023 - 2029, USD Million
TABLE 9 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 11 North America Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 12 North America Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 13 North America Non-systemic Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Non-systemic Market by Country, 2023 - 2029, USD Million
TABLE 15 North America Systemic Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Systemic Market by Country, 2023 - 2029, USD Million
TABLE 17 North America Antacids Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 North America Antacids Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 19 North America Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 21 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 23 North America Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 25 North America Antacids Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Antacids Market by Country, 2023 - 2029, USD Million
TABLE 27 US Antacids Market, 2019 - 2022, USD Million
TABLE 28 US Antacids Market, 2023 - 2029, USD Million
TABLE 29 US Antacids Market by Formulation Type, 2019 - 2022, USD Million
TABLE 30 US Antacids Market by Formulation Type, 2023 - 2029, USD Million
TABLE 31 US Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 32 US Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 33 US Antacids Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 US Antacids Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 35 Canada Antacids Market, 2019 - 2022, USD Million
TABLE 36 Canada Antacids Market, 2023 - 2029, USD Million
TABLE 37 Canada Antacids Market by Formulation Type, 2019 - 2022, USD Million
TABLE 38 Canada Antacids Market by Formulation Type, 2023 - 2029, USD Million
TABLE 39 Canada Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 40 Canada Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 41 Canada Antacids Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 Canada Antacids Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 43 Mexico Antacids Market, 2019 - 2022, USD Million
TABLE 44 Mexico Antacids Market, 2023 - 2029, USD Million
TABLE 45 Mexico Antacids Market by Formulation Type, 2019 - 2022, USD Million
TABLE 46 Mexico Antacids Market by Formulation Type, 2023 - 2029, USD Million
TABLE 47 Mexico Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 48 Mexico Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 49 Mexico Antacids Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 Mexico Antacids Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 51 Rest of North America Antacids Market, 2019 - 2022, USD Million
TABLE 52 Rest of North America Antacids Market, 2023 - 2029, USD Million
TABLE 53 Rest of North America Antacids Market by Formulation Type, 2019 - 2022, USD Million
TABLE 54 Rest of North America Antacids Market by Formulation Type, 2023 - 2029, USD Million
TABLE 55 Rest of North America Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 56 Rest of North America Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 57 Rest of North America Antacids Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Rest of North America Antacids Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 59 Key Information – Abbott Laboratories
TABLE 60 Key Information – Alkem Laboratories Ltd.
TABLE 61 Key Information – Bayer AG
TABLE 62 Key Information – Cipla Limited
TABLE 63 Key Information – Pfizer, Inc.
TABLE 64 Key Information – Prestige Consumer Healthcare, Inc.
TABLE 65 Key information – Reckitt Benckiser Group PLC
TABLE 66 Key Information – WellSpring Pharmaceutical Corporation
TABLE 67 Key Information – Sanofi S.A.
TABLE 68 Key Information – Sun Pharmaceutical Industries Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Antacids Market share by Formulation Type, 2022
FIG 3 North America Antacids Market share by Formulation Type, 2029
FIG 4 North America Antacids Market by Formulation Type, 2019 - 2029, USD Million
FIG 5 North America Antacids Market by Mechanism share of Action, 2022
FIG 6 North America Antacids Market share by Mechanism of Action, 2029
FIG 7 North America Antacids Market by Mechanism of Action, 2019 - 2029, USD Million
FIG 8 North America Antacids Market share by Distribution Channel, 2022
FIG 9 North America Antacids Market share by Distribution Channel, 2029
FIG 10 North America Antacids Market by Distribution Channel, 2019 - 2029, USD Million
FIG 11 North America Antacids Market share by Country, 2022
FIG 12 North America Antacids Market share by Country, 2029
FIG 13 North America Antacids Market by Country, 2019 - 2029, USD Million
FIG 14 Swot analysis: Abbott laboratories
FIG 15 Swot analysis: bayer ag